Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014
5 Visualizzazioni
• 07/30/23
0
0
Incorporare
administrator
Iscritti
Dr. Carvajal, Director of Developmental Therapeutics and Assistant Attending Physician at Memorial Sloan Kettering Cancer Center describes the future of immunotherapy and clinical trials for metastatic melanoma.
Agency: BoldSpark
Director: Sean Willis
BoldSparkCollective.com
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti